Hiv Drugs
-
{
- All
- News
- Videos
-
Mpox Can Infect And Replicate In The Brain, NIH Researchers Say In Fatal HIV Case
A US autopsy found drugresistant mpox replicating in the brain of a man with advanced HIV, raising concerns as global health funding faces cuts.
-
Delhi Man Critical After AI Advice: Risks Of HIV Drug Misuse Explained
A Delhi man was left critically ill after taking HIV preventive medication on an AI chatbot's advice without medical supervision. Pre-Exposure Prophylaxis (PrEP) is proven for HIV prevention when properly prescribed, but dangerous when AI gives it.
-
Top Scientific Discoveries Of 2025: A Year of Quantum Leaps And Cosmic Revelations
Here's a look at scientific discoveries and breakthroughs that made headlines in 2025, spanning space, biology, ecology, and fundamental physics.
-
"Fresh Hope": Groundbreaking HIV Prevention Shots Begin In Africa
South Africa, Eswatini and Zambia on Monday began administering a groundbreaking new HIV-prevention injection in the drug's first public rollouts in Africa, which has the world's highest HIV burden.
-
Why 'Bluetoothing', A Shocking Blood-Sharing Trend To Get High, Has Health Experts Worried
Bluetoothing is a practice where one person injects themselves with a drug, then another person injects that first users blood into their own body
-
HIV-Prevention Drug To Be Available For Rs 3,500 A Year From 2027
Generic versions of a groundbreaking injectable HIV-prevention drug should be available for $40 or Rs 3,548 a year in more than 100 countries from 2027, Unitaid and the Gates Foundation said Wednesday.
-
EU Regulator Approves Twice-Yearly Injectable Drug For HIV Prevention
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus' transmission.
-
Why We Still Need A Cure For HIV Despite Powerful Treatments
Over the past three decades there have been amazing advances in treating and preventing HIV.
-
Revolutionary New Drug Offers 99.9% Protection Against HIV
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high costs may limit its global impact.
-
Sex Workers, Drug Addicts, HIV Patients: An Outcast Haven On Ukraine Front
Whenever warm days come to Kramatorsk, near the eastern Ukrainian front, the Svitanok organisation leaves its door wide open, offering advice or a cup of tea to the city's social outcasts.
-
Mpox Can Infect And Replicate In The Brain, NIH Researchers Say In Fatal HIV Case
A US autopsy found drugresistant mpox replicating in the brain of a man with advanced HIV, raising concerns as global health funding faces cuts.
-
Delhi Man Critical After AI Advice: Risks Of HIV Drug Misuse Explained
A Delhi man was left critically ill after taking HIV preventive medication on an AI chatbot's advice without medical supervision. Pre-Exposure Prophylaxis (PrEP) is proven for HIV prevention when properly prescribed, but dangerous when AI gives it.
-
Top Scientific Discoveries Of 2025: A Year of Quantum Leaps And Cosmic Revelations
Here's a look at scientific discoveries and breakthroughs that made headlines in 2025, spanning space, biology, ecology, and fundamental physics.
-
"Fresh Hope": Groundbreaking HIV Prevention Shots Begin In Africa
South Africa, Eswatini and Zambia on Monday began administering a groundbreaking new HIV-prevention injection in the drug's first public rollouts in Africa, which has the world's highest HIV burden.
-
Why 'Bluetoothing', A Shocking Blood-Sharing Trend To Get High, Has Health Experts Worried
Bluetoothing is a practice where one person injects themselves with a drug, then another person injects that first users blood into their own body
-
HIV-Prevention Drug To Be Available For Rs 3,500 A Year From 2027
Generic versions of a groundbreaking injectable HIV-prevention drug should be available for $40 or Rs 3,548 a year in more than 100 countries from 2027, Unitaid and the Gates Foundation said Wednesday.
-
EU Regulator Approves Twice-Yearly Injectable Drug For HIV Prevention
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus' transmission.
-
Why We Still Need A Cure For HIV Despite Powerful Treatments
Over the past three decades there have been amazing advances in treating and preventing HIV.
-
Revolutionary New Drug Offers 99.9% Protection Against HIV
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high costs may limit its global impact.
-
Sex Workers, Drug Addicts, HIV Patients: An Outcast Haven On Ukraine Front
Whenever warm days come to Kramatorsk, near the eastern Ukrainian front, the Svitanok organisation leaves its door wide open, offering advice or a cup of tea to the city's social outcasts.
